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Introduction
Tumors in the prevascular compartment of the mediastinum 
are rare and imaging plays a major role in their detection, 
(differential) diagnosis, staging, and follow-up. The 
prevascular compartment is bordered anteriorly by the 
posterior aspect of the sternum, posteriorly by the ventral 
aspect of the pericardium, cranially by the thoracic outlet, 
and caudally by the diaphragm (1). 
The differential diagnosis of mediastinal masses, in 
general, is primarily based on the location of the mass, its 
tissue composition (i.e., fat content, calcifications) and the 
age of the patient. The differential diagnosis of masses in 
the pre-vascular mediastinum are commonly referred to as 
the “terrible Ts” (Table 1) (2). 
Imaging of lesions in the prevascular 
compartment
In many cases, the diagnosis of a lesion in the prevascular 
compartment is an incidental finding either on chest 
radiograph (CR) or on computed tomography (CT) 
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scans. For thymomas, few patients present with symptoms 
like myasthenia (and only about 15% of patients with 
myasthenia actually have a thymoma). For thymic 
neoplasms in general, symptoms may be caused by local 
extension and compression of neighboring structures. 
CT
In cases where the suspicion of a mediastinal lesion is 
raised on CR, further imaging work-up is warranted. The 
imaging modality of choice to further evaluate masses in 
the prevascular compartment is contrast-enhanced CT, as it 
enables the visualization of mediastinal masses with a high-
spatial and temporal resolution. Furthermore, CT allows 
for the characterization of tissue components in mediastinal 
masses, which has a major impact on the differential 
diagnosis of mediastinal masses. In particular, the proof 
of fat within a heterogeneous mass in the prevascular 
compartment is critical, as this is virtually diagnostic for a 
benign teratoma (Figure 1) (1). In addition, calcifications or 
cystic components are of diagnostic value.
The role of CT in the evaluation of masses in the 
prevascular compartment was shown in a study among 
127 patients with histologically verified masses of the 
prevascular mediastinum (3). In this study, the first-choice 
CT diagnosis was correct in 61% of the cases, whereas the 
first-choice MR diagnosis was correct in only 56% (3). 
In addition to its role in the differential diagnosis, CT is 
also an indispensable tool for the staging of masses in the 
prevascular mediastinum, as it allows a determination of 
local invasion and lymph node status.
Magnetic resonance imaging (MRI)
While CT is the imaging method of choice for the initial 
evaluation of masses in the prevascular mediastinum, MRI 
is used as a problem-solving tool to further investigate 
known masses. MRI has proven to be a valuable tool in 
the differentiation of normal thymus, thymic hyperplasia, 
and neoplastic lesions, as well as vascular invasion. MRI is 
particularly helpful for the diagnosis and characterization 
of cystic lesions (Figure 2) and for discerning thymic 
hyperplasia from other thymic masses (Figure 3) (4). 
Whereas thymic hyperplasia shows a decrease in signal 
intensity in chemical-shift MRI, other thymic tumors do 
not show this decrease in signal.
Positron emission tomography (PET)
The role of nuclear medicine and particularly PET 
using fluorodeoxyglucose (FDG) as a tracer is not well 
established. Although higher FDG uptake values indicate 
malignancy, biopsy confirmation is also still required, as 
masses with low FDG uptake may be malignant and masses 
with a high FDG uptake can be benign (1). Consequently, 
FDG-PET/CT is primarily used for lymphomas, in lymph 
node staging, and for the detection of distant metastases.
Differential diagnosis of masses in the pre-
vascular mediastinum
Thymic masses
Normal thymus
Generally, the thymus appears as a soft tissue structure in 
the anterior mediastinum. In newborns, the gland defines 
the contour of the mediastinum on plain radiographs. 
During puberty, the normal thymus gland continues to 
grow, reaching its peak weight at approximately 19 years of 
age. Subsequently, the thymus shrinks in size and undergoes 
lipomatous degeneration. By 40 to 60 years of age, the 
gland is mostly replaced by fatty tissue. On imaging studies, 
the thymus appears as a triangular-shaped structure with 
variable fat content. The edges of the normal thymus are 
straight or even concave. The size may vary according to 
age, as outlined above; several authors have also described a 
considerable variation with inspiratory levels (5).
Table 1 Differential diagnosis of masses in the pre-vascular 
mediastinum (2)
Thymic masses
Thymic hyperplasia
Thymic rebound
Thymoma
Thymic cancer
Thymic cysts
Thyroid masses
Thyroid goiter
Thyroid cancer
Terrible lymphomas
Teratomas (Germ cell tumors)
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Thymic cyst
Thymic cysts may be congenital or acquired, and have an 
unilocular or multilocular appearance with a thin wall. 
The CT density of the liquid content ranges between 
~20 to 60 Hounsfield units, depending on the presence of 
associated hemorrhage or infection. MRI greatly facilitates 
the diagnosis of cysts by showing fluid-like signal in T2-
weighted sequences (6). Differential diagnoses of thymic 
cysts are cystic thymomas or germ cell tumors, which show 
contrast-enhancing septa, whereas thymic cysts do not 
present with internal enhancement (6).
Thymic hyperplasia
Thymic hyperplasia or rebound may occur at any age 
due to exogenous stressors and/or illness. On CT, thymic 
hyperplasia is characterized by new growth of soft tissue 
in the anterior mediastinum beyond the mentioned age 
characteristics. In addition, bulky and convex borders 
indicate growth. Whereas the patient’s history may suggest 
thymic rebound, with CT alone, no formal differentiation 
from malignant lesions is feasible. However, MR imaging 
has proven to be a valuable method by which to discern 
normal thymus and hyperplasia from thymic neoplasm. 
Ackman et al. were able to show that chemical-shift imaging 
could reliably differentiate between benign hyperplasia and 
malignant tumors. On in- and out-of-phase gradient-echo 
(GRE) imaging, thymus and thymic hyperplasia show a 
decrease in signal intensity on out-of-phase images because 
of the presence of microscopic fat (Figure 3). In contrast, 
thymic neoplasms do not exhibit decreasing signal intensity 
on opposed-phase GRE imaging (7).
Figure 1 A 9-year-old female patient with increasing shortness 
of breath and chest pain. CT revealed an extensive mass in the 
prevascular compartment with areas of fat (Asterix) and coarse 
calcification (arrowheads). Histology of the resected tumor 
confirmed the suspicion of a mature teratoma
Figure 2 A 64-year-old male patient with an incidental finding of a soft tissue mass in the prevascular mediastinum. (A) CT shows a 
homogenous, well defined oval shaped mass (Asterix). (B) On the corresponding MRI the mass appears as thin walled lesion with a 
homogenous hyperintense content, corresponding to a thymic cyst
BA
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Thymic epithelial malignancies
Thymic epithelial tumors are truly rare entities, with an 
incidence between 0.3 to 1.5 per million per year. Epithelial 
tumors are stratified into thymoma (Figure 4), thymic 
carcinoma (Figure 5), and neuroendocrine tumors of the 
thymus (4). On imaging, a differentiation of these entities is 
not reliably feasible. 
As outlined above, CT is mainly applied for staging in 
these patients. Thymic malignancies are staged according 
to the TNM staging system (UICC 8th edition) released in 
2017 (8). The TNM staging of thymic epithelial tumors is 
briefly summarized in Table 2. 
Contrast-enhanced CT is capable of depicting local 
infiltration of the lungs, the brachiocephalic vein and the 
vena cava, the pulmonary arteries, and the aorta, as well 
as the trachea and esophagus, thus helping to separate 
the different tumor stages (9). Furthermore, macroscopic 
pleural invasion can be detected. Infiltration is suspected if 
either direct invasion is seen, or, if there is a broad contact 
between the lesion and other structures. With increasing 
contact area, infiltration becomes more likely. However, 
the assessment of a peri- and/or myocardial invasion 
can be challenging at times because of limited soft tissue 
resolution. Additional MR imaging can be helpful in the 
evaluation of cardiac and vessel involvement. 
Local lymph node metastasis can be assessed with either 
CT or PET/CT. In cases where imaging reveals equivocal 
results, tissue sampling might be required. 
Thyroid masses
Thyroid goiter
Thyroid goiters account for about 10% of all mediastinal 
masses and are, in most cases (75% to 90% of all cases), 
located in the prevascular compartment (10). Due to their 
expansive growth, thyroid goiters can lead to a displacement 
or narrowing of the trachea. The radiological diagnosis of 
thyroid goiters is usually straightforward, as they appear 
hyperdense on non-enhanced CT scans (>100 HU) and 
show a prolonged enhancement on contrast-enhanced 
scans (10). Calcifications are commonly seen.
Thyroid cancers
Mediastinal thyroid cancers should be suspected in ill-
defined thyroid masses or in case of regional lymph node 
Figure 3 MRI of a 33-year-old male patient four years after lung transplantation. On the T1-weighted sequence, there is an oval-shaped 
mass in the prevascular compartment (arrows), which shows a drop in signal on the T1 opposed-phase sequence, confirming the suspicion of 
a thymic hyperplasia (thymic rebound).
T1 opposed-phaseT1 in-phase
Figure 4 A 51-year-old male patient with an incidental finding of 
a mass in the anterior mediastinum. CT shows a soft-tissue mass 
in the anterior mediastinum with coarse calcifications (arrowhead). 
Biopsy revealed a thymoma.
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enlargement.
(Terrible) Lymphoma
Lymphomas account for up to 20% of mediastinal tumors 
in adults. The mean age at diagnosis is 30 years (11). 
Mediastinal tumors are usually seen as part of a thymic 
involvement of a systemic disease. About 50% to 70% of 
mediastinal lymphomas are Hodgkin’s lymphomas (11). 
On CT, mediastinal lymphomas typically present as 
a large homogenous lobulated or nodular mass in the 
prevascular compartment that may encircle vascular 
structures, but does not infiltrate them (Figure 6) (1). 
The latter feature is helpful in discriminating mediastinal 
lymphomas from malignant epithelial tumors, which tend 
to infiltrate neighboring structures. Prior to treatment, 
mediastinal lymphomas usually do not appear calcified, 
which is also an important aspect to be considered in the 
differential diagnosis. Furthermore, some mediastinal 
lymphomas may show areas of tissue necrosis.
While the use of FDG PET/CT in epithelial tumors of 
the thymus is debatable, FDG PET/CT is a cornerstone 
in the staging of mediastinal lymphomas. As patients with 
mediastinal lymphomas are typically rather young, MRI 
with the use of diffusion-weighted images is an attractive 
alternative to PET/CT in this scenario (12). 
Mediastinal germ cell tumors
Germ cell tumors originate from primitive germ cell layers, 
which may be found dispersed in the anterior mediastinum as 
a result of aberrant migration of primordial germ cells (11). 
In adults, germ cell tumors account for up to 15% of all 
mediastinal tumors (11). Germ cell tumors are subdivided 
into germinomatous and non-germinomatous germ 
cell tumors. Germinomatous germ cell tumors include 
seminomas and germinomas. Non-germinomatous tumors 
include all other germ cell tumors. The most common 
germ cell tumors are teratomas, which frequently present 
with distinct imaging features. Most are mature (benign) 
and, on CT, they commonly present as a well-defined mass 
in the anterior mediastinum with a variable extent of cystic 
degeneration, calcification, and areas of fatty tissue (10). 
Suggestive for malignant teratomas are focal contrast-
enhancing areas or signs of an infiltration of neighboring 
structures (10). 
Seminomas, the second most common type of germ 
cell tumors, present as a homogenous mass in the anterior 
mediastinum, and consequently, share imaging features with 
mediastinal lymphomas (4). Elevated serum β-HCG levels 
associated with normal alpha-fetoprotein levels may help 
with the diagnosis, which can be observed in up to 10% of 
Figure 5 A 39-year-old female patient with increasing fatigue and 
shortness of breath. The CT scan shows a mostly homogenous, 
partly ill-defined mass in the prevascular compartment. Biopsy 
revealed a squamous cell carcinoma of the thymus (Asterix).
Table 2 TNM staging of thymic epithelial tumors (8)
Descriptor Definition
T Descriptor
T1a Encapsulated or unencapsulated, with or 
without extension into mediastinal fat
T1b Extension into mediastinal pleura
T2 Involvement of pericardium
T3 Involvement of lung, brachiocephalic vein, 
superior vena cava, chest wall, phrenic 
nerve, hilar (extrapericardial) pulmonary 
vessels
T4 Involvement of aorta, arch vessels, main 
pulmonary artery,
myocardium, trachea, or esophagus
N Descriptor
N0 No lymph node involvement
N1 Anterior (perithymic) lymph nodes
N2 Deep intrathoracic or cervical lymph nodes
M Descriptor
M1a Separate pleural or pericardial nodule(s)
M1b Pulmonary intraparenchymal nodule or 
distant organ metastasis
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patients with mediastinal seminomas (4).
Conclusions
Imaging plays a pivotal role in the evaluation of masses in 
the prevascular compartment. CT is the imaging method 
of choice to investigate patients with such masses, as it has 
an excellent spatial and temporal resolution. While certain 
masses, such as goiter and teratomas, have pathognomonic 
CT features, others require further evaluation using MRI 
or a biopsy.
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